| Year |
Citation |
Score |
| 2023 |
Ogawa Y, Lim BC, George S, Oses-Prieto JA, Rasband JM, Eshed-Eisenbach Y, Hamdan H, Nair S, Boato F, Peles E, Burlingame AL, Van Aelst L, Rasband MN. Antibody-directed extracellular proximity biotinylation reveals that Contactin-1 regulates axo-axonic innervation of axon initial segments. Nature Communications. 14: 6797. PMID 37884508 DOI: 10.1038/s41467-023-42273-8 |
0.396 |
|
| 2023 |
Eshed-Eisenbach Y, Brophy PJ, Peles E. Nodes of Ranvier in health and disease. Journal of the Peripheral Nervous System : Jpns. PMID 37272548 DOI: 10.1111/jns.12568 |
0.419 |
|
| 2023 |
Ogawa Y, Lim BC, George S, Oses-Prieto JA, Rasband JM, Eshed-Eisenbach Y, Nair S, Boato F, Peles E, Burlingame AL, Aelst LV, Rasband MN. Antibody-directed extracellular proximity biotinylation reveals Contactin-1 regulates axo-axonic innervation of axon initial segments. Biorxiv : the Preprint Server For Biology. PMID 36945454 DOI: 10.1101/2023.03.06.531378 |
0.402 |
|
| 2023 |
Kozar-Gillan N, Velichkova A, Kanatouris G, Eshed-Eisenbach Y, Steel G, Jaegle M, Aunin E, Peles E, Torsney C, Meijer DN. LGI3/2-ADAM23 interactions cluster Kv1 channels in myelinated axons to regulate refractory period. The Journal of Cell Biology. 222. PMID 36828548 DOI: 10.1083/jcb.202211031 |
0.409 |
|
| 2021 |
Repudi S, Steinberg DJ, Elazar N, Breton VL, Aquilino MS, Saleem A, Abu-Swai S, Vainshtein A, Eshed-Eisenbach Y, Vijayaragavan B, Behar O, Hanna JJ, Peles E, Carlen PL, Aqeilan RI. Neuronal deletion of Wwox, associated with WOREE syndrome, causes epilepsy and myelin defects. Brain : a Journal of Neurology. PMID 33914858 DOI: 10.1093/brain/awab174 |
0.314 |
|
| 2021 |
Rebelo AP, Cortese A, Abraham A, Eshed-Eisenbach Y, Shner G, Vainshtein A, Buglo E, Camarena V, Gaidosh G, Shiekhattar R, Abreu L, Courel S, Burns DK, Bai Y, Bacon C, ... ... Peles E, et al. A CADM3 variant causes Charcot-Marie-Tooth disease with marked upper limb involvement. Brain : a Journal of Neurology. PMID 33889941 DOI: 10.1093/brain/awab019 |
0.457 |
|
| 2021 |
Chang KJ, Agrawal I, Vainshtein A, Ho WY, Xin W, Tucker-Kellogg G, Susuki K, Peles E, Ling SC, Chan JR. TDP-43 maximizes nerve conduction velocity by repressing a cryptic exon for paranodal junction assembly in Schwann cells. Elife. 10. PMID 33689679 DOI: 10.7554/eLife.64456 |
0.341 |
|
| 2021 |
Sukhanov N, Vainshtein A, Eshed-Eisenbach Y, Peles E. Differential contribution of Cadm1-Cadm3 cell adhesion molecules to peripheral myelinated axons. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. PMID 33397712 DOI: 10.1523/JNEUROSCI.2736-20.2020 |
0.451 |
|
| 2020 |
Rasband MN, Peles E. Mechanisms of node of Ranvier assembly. Nature Reviews. Neuroscience. PMID 33239761 DOI: 10.1038/s41583-020-00406-8 |
0.379 |
|
| 2020 |
Elazar N, Peles E. Schwann-cell-derived CMTM6 restricts radial axonal growth. Nature Communications. 11: 5044. PMID 33028828 DOI: 10.1038/s41467-020-18886-8 |
0.355 |
|
| 2020 |
Katanov C, Novak N, Vainshtein A, Golani O, Dupree JL, Peles E. N-Wasp regulates oligodendrocyte myelination. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. PMID 32601246 DOI: 10.1523/Jneurosci.0912-20.2020 |
0.521 |
|
| 2020 |
Zhang Y, Yuen S, Peles E, Salzer JL. Accumulation of Neurofascin at nodes of Ranvier is regulated by a Paranodal Switch. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. PMID 32554548 DOI: 10.1523/Jneurosci.0830-19.2020 |
0.403 |
|
| 2020 |
Eshed-Eisenbach Y, Devaux J, Vainshtein A, Golani O, Lee SJ, Feinberg K, Sukhanov N, Greenspan DS, Susuki K, Rasband MN, Peles E. Precise Spatiotemporal Control of Nodal Na Channel Clustering by Bone Morphogenetic Protein-1/Tolloid-like Proteinases. Neuron. PMID 32209430 DOI: 10.1016/J.Neuron.2020.03.001 |
0.775 |
|
| 2019 |
Eshed-Eisenbach Y, Peles E. Clustering of voltage gated sodium channel in various excitable membranes. Developmental Neurobiology. PMID 31859465 DOI: 10.1002/Dneu.22728 |
0.462 |
|
| 2019 |
Djannatian M, Timmler S, Arends M, Luckner M, Weil MT, Alexopoulos I, Snaidero N, Schmid B, Misgeld T, Möbius W, Schifferer M, Peles E, Simons M. Two adhesive systems cooperatively regulate axon ensheathment and myelin growth in the CNS. Nature Communications. 10: 4794. PMID 31641127 DOI: 10.1038/S41467-019-12789-Z |
0.527 |
|
| 2019 |
Elazar N, Vainshtein A, Rechav K, Tsoory M, Eshed-Eisenbach Y, Peles E. Coordinated internodal and paranodal adhesion controls accurate myelination by oligodendrocytes. The Journal of Cell Biology. PMID 31451613 DOI: 10.1083/Jcb.201906099 |
0.531 |
|
| 2019 |
Elazar N, Vainshtein A, Golan N, Vijayaragavan B, Schaeren-Wiemers N, Eshed-Eisenbach Y, Peles E. Axoglial Adhesion by Cadm4 Regulates CNS Myelination. Neuron. 101: 224-231.e5. PMID 30551998 DOI: 10.1016/J.Neuron.2018.11.032 |
0.815 |
|
| 2018 |
Dawes JM, Weir GA, Middleton SJ, Patel R, Chisholm KI, Pettingill P, Peck LJ, Sheridan J, Shakir A, Jacobson L, Gutierrez-Mecinas M, Galino J, Walcher J, Kühnemund J, Kuehn H, ... ... Peles E, et al. Immune or Genetic-Mediated Disruption of CASPR2 Causes Pain Hypersensitivity Due to Enhanced Primary Afferent Excitability. Neuron. PMID 29429934 DOI: 10.1016/J.Neuron.2018.01.033 |
0.311 |
|
| 2017 |
Scott R, Sánchez-Aguilera A, van Elst K, Lim L, Dehorter N, Bae SE, Bartolini G, Peles E, Kas MJH, Bruining H, Marín O. Loss of Cntnap2 Causes Axonal Excitability Deficits, Developmental Delay in Cortical Myelination, and Abnormal Stereotyped Motor Behavior. Cerebral Cortex (New York, N.Y. : 1991). PMID 29300891 DOI: 10.1093/Cercor/Bhx341 |
0.494 |
|
| 2017 |
Bang ML, Vainshtein A, Yang HJ, Eshed-Eisenbach Y, Devaux J, Werner HB, Peles E. Glial M6B stabilizes the axonal membrane at peripheral nodes of Ranvier. Glia. PMID 29282769 DOI: 10.1002/Glia.23285 |
0.512 |
|
| 2017 |
Brivio V, Faivre-Sarrailh C, Peles E, Sherman DL, Brophy PJ. Assembly of CNS Nodes of Ranvier in Myelinated Nerves Is Promoted by the Axon Cytoskeleton. Current Biology : Cb. PMID 28318976 DOI: 10.1016/J.Cub.2017.01.025 |
0.533 |
|
| 2017 |
Amor V, Zhang C, Vainshtein A, Zhang A, Zollinger DR, Eshed-Eisenbach Y, Brophy PJ, Rasband MN, Peles E. The paranodal cytoskeleton clusters Na(+) channels at nodes of Ranvier. Elife. 6. PMID 28134616 DOI: 10.7554/Elife.21392 |
0.476 |
|
| 2016 |
Redmond SA, Mei F, Eshed-Eisenbach Y, Osso LA, Leshkowitz D, Shen YA, Kay JN, Aurrand-Lions M, Lyons DA, Peles E, Chan JR. Somatodendritic Expression of JAM2 Inhibits Oligodendrocyte Myelination. Neuron. PMID 27499083 DOI: 10.1016/J.Neuron.2016.07.021 |
0.496 |
|
| 2016 |
Doppler K, Appeltshauser L, Villmann C, Martin C, Peles E, Krämer HH, Haarmann A, Buttmann M, Sommer C. Auto-antibodies to contactin-associated protein 1 (Caspr) in two patients with painful inflammatory neuropathy. Brain : a Journal of Neurology. PMID 27474220 DOI: 10.1093/Brain/Aww189 |
0.334 |
|
| 2016 |
Eshed-Eisenbach Y, Gordon A, Sukhanov N, Peles E. Specific inhibition of secreted NRG1 types I-II by heparin enhances Schwann Cell myelination. Glia. PMID 27143444 DOI: 10.1002/Glia.22995 |
0.492 |
|
| 2016 |
Yang HJ, Vainshtein A, Maik-Rachline G, Peles E. G protein-coupled receptor 37 is a negative regulator of oligodendrocyte differentiation and myelination. Nature Communications. 7: 10884. PMID 26961174 DOI: 10.1038/Ncomms10884 |
0.495 |
|
| 2016 |
Amor V, Zhang C, Vainshtein A, Zhang A, Zollinger DR, Eshed-Eisenbach Y, Brophy PJ, Rasband MN, Peles E. Author response: The paranodal cytoskeleton clusters Na+ channels at nodes of Ranvier Elife. DOI: 10.7554/Elife.21392.013 |
0.32 |
|
| 2015 |
Gordon A, Salomon D, Barak N, Pen Y, Tsoory M, Kimchi T, Peles E. Expression of Cntnap2 (Caspr2) in multiple levels of sensory systems. Molecular and Cellular Neurosciences. PMID 26647347 DOI: 10.1016/J.Mcn.2015.11.012 |
0.308 |
|
| 2015 |
Rasband MN, Peles E. The Nodes of Ranvier: Molecular Assembly and Maintenance. Cold Spring Harbor Perspectives in Biology. PMID 26354894 DOI: 10.1101/Cshperspect.A020495 |
0.502 |
|
| 2015 |
Lossos A, Elazar N, Lerer I, Schueler-Furman O, Fellig Y, Glick B, Zimmerman BE, Azulay H, Dotan S, Goldberg S, Gomori JM, Ponger P, Newman JP, Marreed H, Steck AJ, ... ... Peles E, et al. Myelin-associated glycoprotein gene mutation causes Pelizaeus-Merzbacher disease-like disorder. Brain : a Journal of Neurology. PMID 26179919 DOI: 10.1093/Brain/Awv204 |
0.456 |
|
| 2015 |
Yaffe Y, Hugger I, Yassaf IN, Shepshelovitch J, Sklan EH, Elkabetz Y, Yeheskel A, Pasmanik-Chor M, Benzing C, Macmillan A, Gaus K, Eshed-Eisenbach Y, Peles E, Hirschberg K. The myelin proteolipid plasmolipin forms oligomers and induces liquid-ordered membranes in the Golgi complex. Journal of Cell Science. 128: 2293-302. PMID 26002055 DOI: 10.1242/Jcs.166249 |
0.436 |
|
| 2015 |
Varea O, Martin-de-Saavedra MD, Kopeikina KJ, Schürmann B, Fleming HJ, Fawcett-Patel JM, Bach A, Jang S, Peles E, Kim E, Penzes P. Synaptic abnormalities and cytoplasmic glutamate receptor aggregates in contactin associated protein-like 2/Caspr2 knockout neurons. Proceedings of the National Academy of Sciences of the United States of America. 112: 6176-81. PMID 25918374 DOI: 10.1073/Pnas.1423205112 |
0.359 |
|
| 2015 |
Chen N, Koopmans F, Gordon A, Paliukhovich I, Klaassen RV, van der Schors RC, Peles E, Verhage M, Smit AB, Li KW. Interaction proteomics of canonical Caspr2 (CNTNAP2) reveals the presence of two Caspr2 isoforms with overlapping interactomes. Biochimica Et Biophysica Acta. 1854: 827-33. PMID 25707359 DOI: 10.1016/J.Bbapap.2015.02.008 |
0.366 |
|
| 2015 |
Colombelli C, Palmisano M, Eshed-Eisenbach Y, Zambroni D, Pavoni E, Ferri C, Saccucci S, Nicole S, Soininen R, McKee KK, Yurchenco PD, Peles E, Wrabetz L, Feltri ML. Perlecan is recruited by dystroglycan to nodes of Ranvier and binds the clustering molecule gliomedin. The Journal of Cell Biology. 208: 313-29. PMID 25646087 DOI: 10.1083/Jcb.201403111 |
0.431 |
|
| 2014 |
Gordon A, Adamsky K, Vainshtein A, Frechter S, Dupree JL, Rosenbluth J, Peles E. Caspr and caspr2 are required for both radial and longitudinal organization of myelinated axons. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 34: 14820-6. PMID 25378149 DOI: 10.1523/Jneurosci.3369-14.2014 |
0.488 |
|
| 2014 |
Roche SL, Sherman DL, Dissanayake K, Soucy G, Desmazieres A, Lamont DJ, Peles E, Julien JP, Wishart TM, Ribchester RR, Brophy PJ, Gillingwater TH. Loss of glial neurofascin155 delays developmental synapse elimination at the neuromuscular junction. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 34: 12904-18. PMID 25232125 DOI: 10.1523/Jneurosci.1725-14.2014 |
0.439 |
|
| 2014 |
Krause MP, Dworski S, Feinberg K, Jones K, Johnston AP, Paul S, Paris M, Peles E, Bagli D, Forrest CR, Kaplan DR, Miller FD. Direct genesis of functional rodent and human schwann cells from skin mesenchymal precursors. Stem Cell Reports. 3: 85-100. PMID 25068124 DOI: 10.1016/J.Stemcr.2014.05.011 |
0.73 |
|
| 2014 |
Amor V, Feinberg K, Eshed-Eisenbach Y, Vainshtein A, Frechter S, Grumet M, Rosenbluth J, Peles E. Long-term maintenance of Na+ channels at nodes of Ranvier depends on glial contact mediated by gliomedin and NrCAM. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 34: 5089-98. PMID 24719088 DOI: 10.1523/Jneurosci.4752-13.2014 |
0.766 |
|
| 2014 |
King CH, Lancaster E, Salomon D, Peles E, Scherer SS. Kv7.2 regulates the function of peripheral sensory neurons. The Journal of Comparative Neurology. 522: 3262-80. PMID 24687876 DOI: 10.1002/Cne.23595 |
0.343 |
|
| 2014 |
Ashrafi S, Betley JN, Comer JD, Brenner-Morton S, Bar V, Shimoda Y, Watanabe K, Peles E, Jessell TM, Kaltschmidt JA. Neuronal Ig/Caspr recognition promotes the formation of axoaxonic synapses in mouse spinal cord. Neuron. 81: 120-9. PMID 24411736 DOI: 10.1016/J.Neuron.2013.10.060 |
0.687 |
|
| 2013 |
Eshed-Eisenbach Y, Peles E. Axonal spectrins: all-purpose fences. The Journal of Cell Biology. 203: 381-3. PMID 24217615 DOI: 10.1083/Jcb.201310070 |
0.473 |
|
| 2013 |
Eshed-Eisenbach Y, Peles E. The making of a node: a co-production of neurons and glia. Current Opinion in Neurobiology. 23: 1049-56. PMID 23831261 DOI: 10.1016/J.Conb.2013.06.003 |
0.495 |
|
| 2013 |
Golan N, Kartvelishvily E, Spiegel I, Salomon D, Sabanay H, Rechav K, Vainshtein A, Frechter S, Maik-Rachline G, Eshed-Eisenbach Y, Momoi T, Peles E. Genetic deletion of Cadm4 results in myelin abnormalities resembling Charcot-Marie-Tooth neuropathy. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 33: 10950-61. PMID 23825401 DOI: 10.1523/Jneurosci.0571-13.2013 |
0.82 |
|
| 2013 |
Susuki K, Chang KJ, Zollinger DR, Liu Y, Ogawa Y, Eshed-Eisenbach Y, Dours-Zimmermann MT, Oses-Prieto JA, Burlingame AL, Seidenbecher CI, Zimmermann DR, Oohashi T, Peles E, Rasband MN. Three mechanisms assemble central nervous system nodes of Ranvier. Neuron. 78: 469-82. PMID 23664614 DOI: 10.1016/J.Neuron.2013.03.005 |
0.46 |
|
| 2013 |
Kinter J, Lazzati T, Schmid D, Zeis T, Erne B, Lützelschwab R, Steck AJ, Pareyson D, Peles E, Schaeren-Wiemers N. An essential role of MAG in mediating axon-myelin attachment in Charcot-Marie-Tooth 1A disease. Neurobiology of Disease. 49: 221-31. PMID 22940629 DOI: 10.1016/J.Nbd.2012.08.009 |
0.504 |
|
| 2012 |
Ivanovic A, Horresh I, Golan N, Spiegel I, Sabanay H, Frechter S, Ohno S, Terada N, Möbius W, Rosenbluth J, Brose N, Peles E. The cytoskeletal adapter protein 4.1G organizes the internodes in peripheral myelinated nerves. The Journal of Cell Biology. 196: 337-44. PMID 22291039 DOI: 10.1083/Jcb.201111127 |
0.813 |
|
| 2012 |
Terada N, Saitoh Y, Ohno N, Komada M, Saitoh S, Peles E, Ohno S. Essential function of protein 4.1G in targeting of membrane protein palmitoylated 6 into Schmidt-Lanterman incisures in myelinated nerves. Molecular and Cellular Biology. 32: 199-205. PMID 22025680 DOI: 10.1128/Mcb.05945-11 |
0.394 |
|
| 2011 |
Shroff S, Mierzwa A, Scherer SS, Peles E, Arevalo JC, Chao MV, Rosenbluth J. Paranodal permeability in "myelin mutants". Glia. 59: 1447-57. PMID 21618613 DOI: 10.1002/Glia.21188 |
0.388 |
|
| 2011 |
Susuki K, Raphael AR, Ogawa Y, Stankewich MC, Peles E, Talbot WS, Rasband MN. Schwann cell spectrins modulate peripheral nerve myelination. Proceedings of the National Academy of Sciences of the United States of America. 108: 8009-14. PMID 21518878 DOI: 10.1073/Pnas.1019600108 |
0.543 |
|
| 2011 |
Lancaster E, Huijbers MG, Bar V, Boronat A, Wong A, Martinez-Hernandez E, Wilson C, Jacobs D, Lai M, Walker RW, Graus F, Bataller L, Illa I, Markx S, Strauss KA, ... Peles E, et al. Investigations of caspr2, an autoantigen of encephalitis and neuromyotonia. Annals of Neurology. 69: 303-11. PMID 21387375 DOI: 10.1002/Ana.22297 |
0.69 |
|
| 2011 |
Novak N, Bar V, Sabanay H, Frechter S, Jaegle M, Snapper SB, Meijer D, Peles E. N-WASP is required for membrane wrapping and myelination by Schwann cells. The Journal of Cell Biology. 192: 243-50. PMID 21263026 DOI: 10.1083/Jcb.201010013 |
0.769 |
|
| 2011 |
Haklai-Topper L, Soutschek J, Sabanay H, Scheel J, Hobert O, Peles E. The neurexin superfamily of Caenorhabditis elegans. Gene Expression Patterns : Gep. 11: 144-50. PMID 21055481 DOI: 10.1016/J.Gep.2010.10.008 |
0.39 |
|
| 2010 |
Irani SR, Alexander S, Waters P, Kleopa KA, Pettingill P, Zuliani L, Peles E, Buckley C, Lang B, Vincent A. Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan's syndrome and acquired neuromyotonia. Brain : a Journal of Neurology. 133: 2734-48. PMID 20663977 DOI: 10.1093/Brain/Awq213 |
0.335 |
|
| 2010 |
Devanathan V, Jakovcevski I, Santuccione A, Li S, Lee HJ, Peles E, Leshchyns'ka I, Sytnyk V, Schachner M. Cellular form of prion protein inhibits Reelin-mediated shedding of Caspr from the neuronal cell surface to potentiate Caspr-mediated inhibition of neurite outgrowth. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 30: 9292-305. PMID 20610764 DOI: 10.1523/Jneurosci.5657-09.2010 |
0.448 |
|
| 2010 |
Feinberg K, Eshed-Eisenbach Y, Frechter S, Amor V, Salomon D, Sabanay H, Dupree JL, Grumet M, Brophy PJ, Shrager P, Peles E. A glial signal consisting of gliomedin and NrCAM clusters axonal Na+ channels during the formation of nodes of Ranvier. Neuron. 65: 490-502. PMID 20188654 DOI: 10.1016/J.Neuron.2010.02.004 |
0.77 |
|
| 2010 |
Horresh I, Bar V, Kissil JL, Peles E. Organization of myelinated axons by Caspr and Caspr2 requires the cytoskeletal adapter protein 4.1B. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 30: 2480-9. PMID 20164332 DOI: 10.1523/Jneurosci.5225-09.2010 |
0.764 |
|
| 2010 |
Ogawa Y, Oses-Prieto J, Kim MY, Horresh I, Peles E, Burlingame AL, Trimmer JS, Meijer D, Rasband MN. ADAM22, a Kv1 channel-interacting protein, recruits membrane-associated guanylate kinases to juxtaparanodes of myelinated axons. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 30: 1038-48. PMID 20089912 DOI: 10.1523/Jneurosci.4661-09.2010 |
0.48 |
|
| 2010 |
Ogawa Y, Oses-Prieto J, Kim MY, Horresh I, Peles E, Burlingame AL, Trimmer J, Meijer D, Rasband M. ADAM22, a Kv1 channel interacting protein, recruits MAGUKs to juxtaparanodes of myelinated axons Neuroscience Research. 68: e235. DOI: 10.1016/J.Neures.2010.07.1039 |
0.506 |
|
| 2009 |
Sun XY, Takagishi Y, Okabe E, Chishima Y, Kanou Y, Murase S, Mizumura K, Inaba M, Komatsu Y, Hayashi Y, Peles E, Oda S, Murata Y. A novel Caspr mutation causes the shambling mouse phenotype by disrupting axoglial interactions of myelinated nerves. Journal of Neuropathology and Experimental Neurology. 68: 1207-18. PMID 19816196 DOI: 10.1097/Nen.0B013E3181Be2E96 |
0.451 |
|
| 2009 |
Grossmann KS, Wende H, Paul FE, Cheret C, Garratt AN, Zurborg S, Feinberg K, Besser D, Schulz H, Peles E, Selbach M, Birchmeier W, Birchmeier C. The tyrosine phosphatase Shp2 (PTPN11) directs Neuregulin-1/ErbB signaling throughout Schwann cell development. Proceedings of the National Academy of Sciences of the United States of America. 106: 16704-9. PMID 19805360 DOI: 10.1073/Pnas.0904336106 |
0.745 |
|
| 2009 |
Eisenbach M, Kartvelishvily E, Eshed-Eisenbach Y, Watkins T, Sorensen A, Thomson C, Ranscht B, Barnett SC, Brophy P, Peles E. Differential clustering of Caspr by oligodendrocytes and Schwann cells. Journal of Neuroscience Research. 87: 3492-501. PMID 19565653 DOI: 10.1002/Jnr.22157 |
0.519 |
|
| 2009 |
Spiegel I, Peles E. A novel method for isolating Schwann cells using the extracellular domain of Necl1. Journal of Neuroscience Research. 87: 3288-96. PMID 19125407 DOI: 10.1002/Jnr.21985 |
0.767 |
|
| 2008 |
Horresh I, Poliak S, Grant S, Bredt D, Rasband MN, Peles E. Multiple molecular interactions determine the clustering of Caspr2 and Kv1 channels in myelinated axons. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 28: 14213-22. PMID 19109503 DOI: 10.1523/Jneurosci.3398-08.2008 |
0.484 |
|
| 2008 |
Salzer JL, Brophy PJ, Peles E. Molecular domains of myelinated axons in the peripheral nervous system. Glia. 56: 1532-40. PMID 18803321 DOI: 10.1002/Glia.20750 |
0.512 |
|
| 2008 |
Golan N, Adamsky K, Kartvelishvily E, Brockschnieder D, Möbius W, Spiegel I, Roth AD, Thomson CE, Rechavi G, Peles E. Identification of Tmem10/Opalin as an oligodendrocyte enriched gene using expression profiling combined with genetic cell ablation. Glia. 56: 1176-86. PMID 18571792 DOI: 10.1002/Glia.20688 |
0.81 |
|
| 2008 |
Ogawa Y, Horresh I, Trimmer JS, Bredt DS, Peles E, Rasband MN. Postsynaptic density-93 clusters Kv1 channels at axon initial segments independently of Caspr2. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 28: 5731-9. PMID 18509034 DOI: 10.1523/Jneurosci.4431-07.2008 |
0.447 |
|
| 2008 |
Shavit E, Beilin O, Korczyn AD, Sylantiev C, Aronovich R, Drory VE, Gurwitz D, Horresh I, Bar-Shavit R, Peles E, Chapman J. Thrombin receptor PAR-1 on myelin at the node of Ranvier: a new anatomy and physiology of conduction block. Brain : a Journal of Neurology. 131: 1113-22. PMID 18299297 DOI: 10.1093/Brain/Awn005 |
0.406 |
|
| 2007 |
Spiegel I, Adamsky K, Eshed Y, Milo R, Sabanay H, Sarig-Nadir O, Horresh I, Scherer SS, Rasband MN, Peles E. A central role for Necl4 (SynCAM4) in Schwann cell-axon interaction and myelination. Nature Neuroscience. 10: 861-9. PMID 17558405 DOI: 10.1038/Nn1915 |
0.782 |
|
| 2007 |
Eshed Y, Feinberg K, Carey DJ, Peles E. Secreted gliomedin is a perinodal matrix component of peripheral nerves. The Journal of Cell Biology. 177: 551-62. PMID 17485493 DOI: 10.1083/Jcb.200612139 |
0.747 |
|
| 2006 |
Spiegel I, Adamsky K, Eisenbach M, Eshed Y, Spiegel A, Mirsky R, Scherer SS, Peles E. Identification of novel cell-adhesion molecules in peripheral nerves using a signal-sequence trap. Neuron Glia Biology. 2: 27-38. PMID 16721426 DOI: 10.1017/S1740925X0600007X |
0.774 |
|
| 2006 |
Ogawa Y, Schafer DP, Horresh I, Bar V, Hales K, Yang Y, Susuki K, Peles E, Stankewich MC, Rasband MN. Spectrins and ankyrinB constitute a specialized paranodal cytoskeleton. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 26: 5230-9. PMID 16687515 DOI: 10.1523/Jneurosci.0425-06.2006 |
0.766 |
|
| 2006 |
Spiegel I, Peles E. A new player in CNS myelination. Neuron. 49: 777-8. PMID 16543121 DOI: 10.1016/J.Neuron.2006.03.001 |
0.757 |
|
| 2006 |
Brockschnieder D, Sabanay H, Riethmacher D, Peles E. Ermin, a myelinating oligodendrocyte-specific protein that regulates cell morphology. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 26: 757-62. PMID 16421295 DOI: 10.1523/Jneurosci.4317-05.2006 |
0.544 |
|
| 2005 |
Eshed Y, Feinberg K, Poliak S, Sabanay H, Sarig-Nadir O, Spiegel I, Bermingham JR, Peles E. Gliomedin mediates Schwann cell-axon interaction and the molecular assembly of the nodes of Ranvier. Neuron. 47: 215-29. PMID 16039564 DOI: 10.1016/J.Neuron.2005.06.026 |
0.822 |
|
| 2005 |
Peles E. Molecular Specializations at the Glia-Axon Interface Multiple Sclerosis as a Neuronal Disease. 45-56. DOI: 10.1016/B978-012738761-1/50004-3 |
0.462 |
|
| 2004 |
Corfas G, Velardez MO, Ko CP, Ratner N, Peles E. Mechanisms and roles of axon-Schwann cell interactions. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 24: 9250-60. PMID 15496660 DOI: 10.1523/Jneurosci.3649-04.2004 |
0.493 |
|
| 2004 |
Ulzheimer JC, Peles E, Levinson SR, Martini R. Altered expression of ion channel isoforms at the node of Ranvier in P0-deficient myelin mutants. Molecular and Cellular Neurosciences. 25: 83-94. PMID 14962742 DOI: 10.1016/J.Mcn.2003.09.015 |
0.479 |
|
| 2003 |
Poliak S, Peles E. The local differentiation of myelinated axons at nodes of Ranvier. Nature Reviews. Neuroscience. 4: 968-80. PMID 14682359 DOI: 10.1038/Nrn1253 |
0.559 |
|
| 2003 |
Gollan L, Salomon D, Salzer JL, Peles E. Caspr regulates the processing of contactin and inhibits its binding to neurofascin. The Journal of Cell Biology. 163: 1213-8. PMID 14676309 DOI: 10.1083/Jcb.200309147 |
0.482 |
|
| 2003 |
Poliak S, Salomon D, Elhanany H, Sabanay H, Kiernan B, Pevny L, Stewart CL, Xu X, Chiu SY, Shrager P, Furley AJ, Peles E. Juxtaparanodal clustering of Shaker-like K+ channels in myelinated axons depends on Caspr2 and TAG-1. The Journal of Cell Biology. 162: 1149-60. PMID 12963709 DOI: 10.1083/Jcb.200305018 |
0.5 |
|
| 2003 |
Adamsky K, Arnold K, Sabanay H, Peles E. Junctional protein MAGI-3 interacts with receptor tyrosine phosphatase beta (RPTP beta) and tyrosine-phosphorylated proteins. Journal of Cell Science. 116: 1279-89. PMID 12615970 DOI: 10.1242/Jcs.00302 |
0.395 |
|
| 2003 |
Scherer SS, Arroyo EJ, Peles E. Functional Organization of the Nodes of Ranvier Myelin Biology and Disorders. 1: 89-116. DOI: 10.1016/B978-012439510-7/50057-7 |
0.43 |
|
| 2002 |
Rasband MN, Park EW, Zhen D, Arbuckle MI, Poliak S, Peles E, Grant SG, Trimmer JS. Clustering of neuronal potassium channels is independent of their interaction with PSD-95. The Journal of Cell Biology. 159: 663-72. PMID 12438413 DOI: 10.1083/Jcb.200206024 |
0.411 |
|
| 2002 |
Poliak S, Matlis S, Ullmer C, Scherer SS, Peles E. Distinct claudins and associated PDZ proteins form different autotypic tight junctions in myelinating Schwann cells. The Journal of Cell Biology. 159: 361-72. PMID 12403818 DOI: 10.1083/Jcb.200207050 |
0.521 |
|
| 2002 |
Girault JA, Peles E. Development of nodes of Ranvier. Current Opinion in Neurobiology. 12: 476-85. PMID 12367625 DOI: 10.1016/S0959-4388(02)00370-7 |
0.564 |
|
| 2002 |
Erez N, Milyavsky M, Goldfinger N, Peles E, Gudkov AV, Rotter V. Falkor, a novel cell growth regulator isolated by a functional genetic screen. Oncogene. 21: 6713-21. PMID 12360397 DOI: 10.1038/Sj.Onc.1205867 |
0.355 |
|
| 2002 |
Ishibashi T, Dupree JL, Ikenaka K, Hirahara Y, Honke K, Peles E, Popko B, Suzuki K, Nishino H, Baba H. A myelin galactolipid, sulfatide, is essential for maintenance of ion channels on myelinated axon but not essential for initial cluster formation. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 22: 6507-14. PMID 12151530 DOI: 10.1523/Jneurosci.22-15-06507.2002 |
0.5 |
|
| 2002 |
Spiegel I, Peles E. Cellular junctions of myelinated nerves (Review). Molecular Membrane Biology. 19: 95-101. PMID 12126235 DOI: 10.1080/09687680210130009 |
0.776 |
|
| 2002 |
Spiegel I, Salomon D, Erne B, Schaeren-Wiemers N, Peles E. Caspr3 and caspr4, two novel members of the caspr family are expressed in the nervous system and interact with PDZ domains. Molecular and Cellular Neurosciences. 20: 283-97. PMID 12093160 DOI: 10.1006/Mcne.2002.1110 |
0.749 |
|
| 2002 |
Gollan L, Sabanay H, Poliak S, Berglund EO, Ranscht B, Peles E. Retention of a cell adhesion complex at the paranodal junction requires the cytoplasmic region of Caspr. The Journal of Cell Biology. 157: 1247-56. PMID 12082082 DOI: 10.1083/Jcb.200203050 |
0.503 |
|
| 2002 |
Bülow HE, Berry KL, Topper LH, Peles E, Hobert O. Heparan sulfate proteoglycan-dependent induction of axon branching and axon misrouting by the Kallmann syndrome gene kal-1. Proceedings of the National Academy of Sciences of the United States of America. 99: 6346-51. PMID 11983919 DOI: 10.1073/Pnas.092128099 |
0.483 |
|
| 2002 |
Arroyo EJ, Xu T, Grinspan J, Lambert S, Levinson SR, Brophy PJ, Peles E, Scherer SS. Genetic dysmyelination alters the molecular architecture of the nodal region. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 22: 1726-37. PMID 11880502 DOI: 10.1523/Jneurosci.22-05-01726.2002 |
0.493 |
|
| 2001 |
Poliak S, Gollan L, Salomon D, Berglund EO, Ohara R, Ranscht B, Peles E. Localization of Caspr2 in myelinated nerves depends on axon-glia interactions and the generation of barriers along the axon. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 21: 7568-75. PMID 11567047 DOI: 10.1523/Jneurosci.21-19-07568.2001 |
0.54 |
|
| 2001 |
Arroyo EJ, Xu T, Poliak S, Watson M, Peles E, Scherer SS. Internodal specializations of myelinated axons in the central nervous system. Cell and Tissue Research. 305: 53-66. PMID 11512672 DOI: 10.1007/S004410100403 |
0.535 |
|
| 2001 |
Brown AA, Xu T, Arroyo EJ, Levinson SR, Brophy PJ, Peles E, Scherer SS. Molecular organization of the nodal region is not altered in spontaneously diabetic BB-Wistar rats. Journal of Neuroscience Research. 65: 139-49. PMID 11438983 DOI: 10.1002/Jnr.1137 |
0.359 |
|
| 2001 |
Boyle ME, Berglund EO, Murai KK, Weber L, Peles E, Ranscht B. Contactin orchestrates assembly of the septate-like junctions at the paranode in myelinated peripheral nerve. Neuron. 30: 385-97. PMID 11395001 DOI: 10.1016/S0896-6273(01)00296-3 |
0.498 |
|
| 2001 |
Adamsky K, Schilling J, Garwood J, Faissner A, Peles E. Glial tumor cell adhesion is mediated by binding of the FNIII domain of receptor protein tyrosine phosphatase β (RPTPβ) to tenascin C Oncogene. 20: 609-618. PMID 11313993 DOI: 10.1038/Sj.Onc.1204119 |
0.402 |
|
| 2001 |
Bécamel C, Figge A, Poliak S, Dumuis A, Peles E, Bockaert J, Lübbert H, Ullmer C. Interaction of Serotonin 5-Hydroxytryptamine Type 2C Receptors with PDZ10 of the Multi-PDZ Domain Protein MUPP1 Journal of Biological Chemistry. 276: 12974-12982. PMID 11150294 DOI: 10.1074/Jbc.M008089200 |
0.357 |
|
| 2001 |
Peles E, Salzer JL. Molecular domains of myelinated axons. Current Opinion in Neurobiology. 10: 558-65. PMID 11084317 DOI: 10.1016/S0959-4388(00)00122-7 |
0.529 |
|
| 2000 |
Rios JC, Melendez-Vasquez CV, Einheber S, Lustig M, Grumet M, Hemperly J, Peles E, Salzer JL. Contactin-associated protein (Caspr) and contactin form a complex that is targeted to the paranodal junctions during myelination. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 20: 8354-64. PMID 11069942 DOI: 10.1523/Jneurosci.20-22-08354.2000 |
0.541 |
|
| 2000 |
Caldwell JH, Schaller KL, Lasher RS, Peles E, Levinson SR. Sodium channel Na(v)1.6 is localized at nodes of ranvier, dendrites, and synapses. Proceedings of the National Academy of Sciences of the United States of America. 97: 5616-20. PMID 10779552 DOI: 10.1073/Pnas.090034797 |
0.46 |
|
| 1999 |
Arroyo EJ, Xu YT, Zhou L, Messing A, Peles E, Chiu SY, Scherer SS. Myelinating Schwann cells determine the internodal localization of Kv1.1, Kv1.2, Kvbeta2, and Caspr. Journal of Neurocytology. 28: 333-47. PMID 10739575 DOI: 10.1023/A:1007009613484 |
0.518 |
|
| 1999 |
Rasband MN, Trimmer JS, Peles E, Levinson SR, Shrager P. K+ channel distribution and clustering in developing and hypomyelinated axons of the optic nerve. Journal of Neurocytology. 28: 319-31. PMID 10739574 DOI: 10.1023/A:1007057512576 |
0.403 |
|
| 1999 |
Poliak S, Gollan L, Martinez R, Custer A, Einheber S, Salzer JL, Trimmer JS, Shrager P, Peles E. Caspr2, a new member of the neurexin superfamily, is localized at the juxtaparanodes of myelinated axons and associates with K+ channels. Neuron. 24: 1037-47. PMID 10624965 DOI: 10.1016/S0896-6273(00)81049-1 |
0.52 |
|
| 1999 |
Rasband MN, Peles E, Trimmer JS, Levinson SR, Lux SE, Shrager P. Dependence of nodal sodium channel clustering on paranodal axoglial contact in the developing CNS. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 19: 7516-28. PMID 10460258 DOI: 10.1523/Jneurosci.19-17-07516.1999 |
0.426 |
|
| 1998 |
Peles E, Schlessinger J, Grumet M. Multi-ligand interactions with receptor-like protein tyrosine phosphatase beta: implications for intercellular signaling. Trends in Biochemical Sciences. 23: 121-4. PMID 9584610 DOI: 10.1016/S0968-0004(98)01195-5 |
0.631 |
|
| 1998 |
Holland SJ, Peles E, Pawson T, Schlessinger J. Cell-contact-dependent signalling in axon growth and guidance: Eph receptor tyrosine kinases and receptor protein tyrosine phosphatase beta. Current Opinion in Neurobiology. 8: 117-27. PMID 9568399 DOI: 10.1016/S0959-4388(98)80015-9 |
0.683 |
|
| 1997 |
Einheber S, Zanazzi G, Ching W, Scherer S, Milner TA, Peles E, Salzer JL. The axonal membrane protein Caspr, a homologue of neurexin IV, is a component of the septate-like paranodal junctions that assemble during myelination. The Journal of Cell Biology. 139: 1495-506. PMID 9396755 DOI: 10.1083/Jcb.139.6.1495 |
0.545 |
|
| 1997 |
Peles E, Nativ M, Lustig M, Grumet M, Schilling J, Martinez R, Plowman GD, Schlessinger J. Identification of a novel contactin-associated transmembrane receptor with multiple domains implicated in protein-protein interactions. The Embo Journal. 16: 978-88. PMID 9118959 DOI: 10.1093/Emboj/16.5.978 |
0.653 |
|
| 1997 |
Peles E, Joho K, Plowman GD, Schlessinger J. Close similarity between Drosophila neurexin IV and mammalian Caspr protein suggests a conserved mechanism for cellular interactions. Cell. 88: 745-6. PMID 9118217 DOI: 10.1016/S0092-8674(00)81920-0 |
0.582 |
|
| 1997 |
Sakurai T, Lustig M, Nativ M, Hemperly JJ, Schlessinger J, Peles E, Grumet M. Induction of neurite outgrowth through contactin and Nr-CAM by extracellular regions of glial receptor tyrosine phosphatase beta. The Journal of Cell Biology. 136: 907-18. PMID 9049255 DOI: 10.1083/Jcb.136.4.907 |
0.64 |
|
| 1995 |
Peles E, Nativ M, Campbell PL, Sakurai T, Martinez R, Lev S, Clary DO, Schilling J, Barnea G, Plowman GD, Grumet M, Schlessinger J. The carbonic anhydrase domain of receptor tyrosine phosphatase beta is a functional ligand for the axonal cell recognition molecule contactin. Cell. 82: 251-60. PMID 7628014 DOI: 10.1016/0092-8674(95)90312-7 |
0.76 |
|
| 1995 |
Lev S, Moreno H, Martinez R, Canoll P, Peles E, Musacchio JM, Plowman GD, Rudy B, Schlessinger J. Protein tyrosine kinase PYK2 involved in Ca(2+)-induced regulation of ion channel and MAP kinase functions. Nature. 376: 737-45. PMID 7544443 DOI: 10.1038/376737A0 |
0.722 |
|
| 1994 |
Tzahari E, Levkowitz G, Karunagaran D, Yi L, Peles E, Lavi S, Chang D, Liu N, Yayon A, Wen D, Yarden Y. ErbB-3 and ErbB-4 function as the respective low and high affinity receptors of all Neu differentiation factor/heregulin isoforms Journal of Biological Chemistry. 269: 25226-25233. PMID 7929212 |
0.651 |
|
| 1993 |
Peles E, Ben-Levy R, Tzahar E, Liu N, Wen D, Yarden Y. Cell-type specific interaction of Neu differentiation factor (NDF/heregulin) with Neu/HER-2 suggests complex ligand-receptor relationships. The Embo Journal. 12: 961-71. PMID 8096177 DOI: 10.1002/J.1460-2075.1993.Tb05737.X |
0.651 |
|
| 1993 |
Peles E, Yarden Y. Neu and its ligands: from an oncogene to neural factors. Bioessays : News and Reviews in Molecular, Cellular and Developmental Biology. 15: 815-24. PMID 7908191 DOI: 10.1002/Bies.950151207 |
0.669 |
|
| 1992 |
Stancovski I, Peles E, Ben Levy R, Lemprecht R, Kelman Z, Goldman-Michael R, Hurwitz E, Bacus S, Sela M, Yarden Y. Signal transduction by the neu/erbB-2 receptor: a potential target for anti-tumor therapy. The Journal of Steroid Biochemistry and Molecular Biology. 43: 95-103. PMID 1356018 DOI: 10.1016/0960-0760(92)90192-L |
0.64 |
|
| 1992 |
Ben-Levy R, Peles E, Goldman-Michael R, Yarden Y. An oncogenic point mutation confers high affinity ligand binding to the neu receptor. Implications for the generation of site heterogeneity. The Journal of Biological Chemistry. 267: 17304-13. PMID 1355090 |
0.589 |
|
| 1992 |
Peles E, Lamprecht R, Ben-Levy R, Tzahar E, Yarden Y. Regulated coupling of the Neu receptor to phosphatidylinositol 3'-kinase and its release by oncogenic activation. The Journal of Biological Chemistry. 267: 12266-74. PMID 1351056 |
0.583 |
|
| 1992 |
Wen D, Peles E, Cupples R, Suggs SV, Bacus SS, Luo Y, Trail G, Hu S, Silbiger SM, Levy RB, Koski RA, Lu HS, Yarden Y. Neu differentiation factor: A transmembrane glycoprotein containing an EGF domain and an immunoglobulin homology unit Cell. 69: 559-572. PMID 1349853 DOI: 10.1016/0092-8674(92)90456-M |
0.648 |
|
| 1992 |
Peles E, Bacus SS, Koski RA, Lu HS, Wen D, Ogden SG, Levy RB, Yarden Y. Isolation of the neu/HER-2 stimulatory ligand: a 44 kd glycoprotein that induces differentiation of mammary tumor cells. Cell. 69: 205-16. PMID 1348215 DOI: 10.1016/0092-8674(92)90131-U |
0.643 |
|
| 1991 |
Peles E, Levy RB, Or E, Ullrich A, Yarden Y. Oncogenic forms of the neu/HER2 tyrosine kinase are permanently coupled to phospholipase C gamma. The Embo Journal. 10: 2077-86. PMID 1676673 DOI: 10.1002/J.1460-2075.1991.Tb07739.X |
0.634 |
|
| 1991 |
Yarden Y, Peles E. Biochemical analysis of the ligand for the neu oncogenic receptor. Biochemistry. 30: 3543-50. PMID 1672825 DOI: 10.1021/Bi00228A027 |
0.622 |
|
| 1990 |
Goldman R, Levy RB, Peles E, Yarden Y. Heterodimerization of the erbB-1 and erbB-2 receptors in human breast carcinoma cells: a mechanism for receptor transregulation. Biochemistry. 29: 11024-8. PMID 1980216 DOI: 10.1021/Bi00502A002 |
0.623 |
|
| Low-probability matches (unlikely to be authored by this person) |
| 2007 |
Sumita K, Sato Y, Iida J, Kawata A, Hamano M, Hirabayashi S, Ohno K, Peles E, Hata Y. Synaptic scaffolding molecule (S-SCAM) membrane-associated guanylate kinase with inverted organization (MAGI)-2 is associated with cell adhesion molecules at inhibitory synapses in rat hippocampal neurons. Journal of Neurochemistry. 100: 154-66. PMID 17059560 DOI: 10.1111/J.1471-4159.2006.04170.X |
0.289 |
|
| 2007 |
Parent AS, Mungenast AE, Lomniczi A, Sandau US, Peles E, Bosch MA, Rønnekleiv OK, Ojeda SR. A contactin-receptor-like protein tyrosine phosphatase beta complex mediates adhesive communication between astroglial cells and gonadotrophin-releasing hormone neurones. Journal of Neuroendocrinology. 19: 847-59. PMID 17927663 DOI: 10.1111/J.1365-2826.2007.01597.X |
0.286 |
|
| 2012 |
Ng JK, Malotka J, Kawakami N, Derfuss T, Khademi M, Olsson T, Linington C, Odaka M, Tackenberg B, Prüss H, Schwab JM, Harms L, Harms H, Sommer C, Rasband MN, ... ... Peles E, et al. Neurofascin as a target for autoantibodies in peripheral neuropathies. Neurology. 79: 2241-8. PMID 23100406 DOI: 10.1212/Wnl.0B013E31827689Ad |
0.279 |
|
| 2012 |
Rosenbluth J, Petzold C, Peles E. Dependence of paranodal junctional gap width on transverse bands. The Journal of Comparative Neurology. 520: 2774-84. PMID 22434587 DOI: 10.1002/Cne.23105 |
0.277 |
|
| 2015 |
Peñagarikano O, Lázaro MT, Lu XH, Gordon A, Dong H, Lam HA, Peles E, Maidment NT, Murphy NP, Yang XW, Golshani P, Geschwind DH. Exogenous and evoked oxytocin restores social behavior in the Cntnap2 mouse model of autism. Science Translational Medicine. 7: 271ra8. PMID 25609168 DOI: 10.1126/Scitranslmed.3010257 |
0.276 |
|
| 2011 |
Peñagarikano O, Abrahams BS, Herman EI, Winden KD, Gdalyahu A, Dong H, Sonnenblick LI, Gruver R, Almajano J, Bragin A, Golshani P, Trachtenberg JT, Peles E, Geschwind DH. Absence of CNTNAP2 leads to epilepsy, neuronal migration abnormalities, and core autism-related deficits. Cell. 147: 235-46. PMID 21962519 DOI: 10.1016/J.Cell.2011.08.040 |
0.275 |
|
| 2014 |
Karayannis T, Au E, Patel JC, Kruglikov I, Markx S, Delorme R, Héron D, Salomon D, Glessner J, Restituito S, Gordon A, Rodriguez-Murillo L, Roy NC, Gogos JA, Rudy B, ... ... Peles E, et al. Cntnap4 differentially contributes to GABAergic and dopaminergic synaptic transmission. Nature. 511: 236-40. PMID 24870235 DOI: 10.1038/Nature13248 |
0.274 |
|
| 2015 |
Brunner D, Kabitzke P, He D, Cox K, Thiede L, Hanania T, Sabath E, Alexandrov V, Saxe M, Peles E, Mills A, Spooren W, Ghosh A, Feliciano P, Benedetti M, et al. Comprehensive Analysis of the 16p11.2 Deletion and Null Cntnap2 Mouse Models of Autism Spectrum Disorder. Plos One. 10: e0134572. PMID 26273832 DOI: 10.1371/Journal.Pone.0134572 |
0.239 |
|
| 2010 |
O'Brien BJ, Hirano AA, Buttermore ED, Bhat MA, Peles E. Localization of the paranodal protein Caspr in the mammalian retina. Molecular Vision. 16: 1854-63. PMID 21031018 |
0.238 |
|
| 1990 |
Peles E, Rosen H, Darai G, Rösen-Wolff A, Becker Y. Importance of the HpaI-P sequence for herpes simplex virus-1 replication in the adrenal glands Archives of Virology. 113: 151-163. PMID 2171454 DOI: 10.1007/Bf01316669 |
0.215 |
|
| 1993 |
Bacus SS, Gudkov AV, Zelnick CR, Chin D, Stern R, Stancovski I, Peles E, Ben-Baruch N, Farbstein H, Lupu R. Neu differentiation factor (heregulin) induces expression of intercellular adhesion molecule 1: implications for mammary tumors. Cancer Research. 53: 5251-61. PMID 8106145 |
0.212 |
|
| 2018 |
Karbian N, Eshed-Eisenbach Y, Tabib A, Hoizman H, Morgan BP, Schueler-Furman O, Peles E, Mevorach D. Molecular pathogenesis of human CD59 deficiency. Neurology. Genetics. 4: e280. PMID 30533526 DOI: 10.1212/Nxg.0000000000000280 |
0.194 |
|
| 2006 |
Martin KC, Peles E. Neuronal and glial cell biology Current Opinion in Neurobiology. 16: 489-491. DOI: 10.1016/j.conb.2006.08.015 |
0.171 |
|
| 2023 |
Karbian N, Eshed-Eisenbach Y, Zeibak M, Tabib A, Sukhanov N, Vainshtein A, Morgan BP, Fellig Y, Peles E, Mevorach D. Complement-membrane regulatory proteins are absent from the nodes of Ranvier in the peripheral nervous system. Journal of Neuroinflammation. 20: 245. PMID 37875972 DOI: 10.1186/s12974-023-02920-9 |
0.162 |
|
| 2015 |
Brunner D, Kabitzke P, He D, Cox K, Thiede L, Hanania T, Sabath E, Alexandrov V, Saxe M, Peles E, Mills A, Spooren W, Ghosh A, Feliciano P, Benedetti M, et al. Acquisition and reversal in the procedural T-maze. Plos One. DOI: 10.1371/Journal.Pone.0134572.G013 |
0.162 |
|
| 2023 |
Sadhu RK, Hernandez-Padilla C, Eisenbach YE, Penič S, Zhang L, Vishwasrao HD, Behkam B, Konstantopoulos K, Shroff H, Iglič A, Peles E, Nain AS, Gov NS. Experimental and theoretical model for the origin of coiling of cellular protrusions around fibers. Nature Communications. 14: 5612. PMID 37699891 DOI: 10.1038/s41467-023-41273-y |
0.101 |
|
| 2012 |
Levran O, Peles E, Hamon S, Randesi M, Zhao C, Zhang B, Adelson M, Kreek MJ. Nerve growth factor β polypeptide (NGFB) genetic variability: association with the methadone dose required for effective maintenance treatment. The Pharmacogenomics Journal. 12: 319-27. PMID 21358750 DOI: 10.1038/Tpj.2011.6 |
0.091 |
|
| 2013 |
Levran O, Peles E, Randesi M, Shu X, Ott J, Shen PH, Adelson M, Kreek MJ. Association of genetic variation in pharmacodynamic factors with methadone dose required for effective treatment of opioid addiction. Pharmacogenomics. 14: 755-68. PMID 23651024 DOI: 10.2217/Pgs.13.58 |
0.062 |
|
| 2008 |
Levran O, Londono D, O'Hara K, Nielsen DA, Peles E, Rotrosen J, Casadonte P, Linzy S, Randesi M, Ott J, Adelson M, Kreek MJ. Genetic susceptibility to heroin addiction: a candidate gene association study. Genes, Brain, and Behavior. 7: 720-9. PMID 18518925 DOI: 10.1111/J.1601-183X.2008.00410.X |
0.052 |
|
| 2021 |
Rebelo AP, Cortese A, Abraham A, Eshed-Eisenbach Y, Shner G, Vainshtein A, Buglo E, Camarena V, Gaidosh G, Shiekhattar R, Abreu L, Courel S, Burns DK, Bai Y, Bacon C, ... ... Peles E, et al. Erratum to: A CADM3 variant causes Charcot-Marie-Tooth disease with marked upper limb involvement. Brain : a Journal of Neurology. PMID 34037698 DOI: 10.1093/brain/awab181 |
0.05 |
|
| 2014 |
Levran O, Peles E, Randesi M, Li Y, Rotrosen J, Ott J, Adelson M, Kreek MJ. Stress-related genes and heroin addiction: a role for a functional FKBP5 haplotype. Psychoneuroendocrinology. 45: 67-76. PMID 24845178 DOI: 10.1016/J.Psyneuen.2014.03.017 |
0.047 |
|
| 2004 |
Peles E, Lidar Z, Simon AJ, Grossman R, Nass D, Ram Z. Angiogenic factors in the cerebrospinal fluid of patients with astrocytic brain tumors Neurosurgery. 55: 562-567. PMID 15335423 DOI: 10.1227/01.NEU.0000134383.27713.9A |
0.045 |
|
| 2008 |
Levran O, O'Hara K, Peles E, Li D, Barral S, Ray B, Borg L, Ott J, Adelson M, Kreek MJ. ABCB1 (MDR1) genetic variants are associated with methadone doses required for effective treatment of heroin dependence. Human Molecular Genetics. 17: 2219-27. PMID 18424454 DOI: 10.1093/Hmg/Ddn122 |
0.045 |
|
| 2015 |
Levran O, Peles E, Randesi M, Correa da Rosa J, Ott J, Rotrosen J, Adelson M, Kreek MJ. Synaptic Plasticity and Signal Transduction Gene Polymorphisms and Vulnerability to Drug Addictions in Populations of European or African Ancestry. Cns Neuroscience & Therapeutics. 21: 898-904. PMID 26384852 DOI: 10.1111/Cns.12450 |
0.043 |
|
| 2014 |
Levran O, Peles E, Randesi M, Correa da Rosa J, Ott J, Rotrosen J, Adelson M, Kreek MJ. Dopaminergic pathway polymorphisms and heroin addiction: further support for association of CSNK1E variants. Pharmacogenomics. 15: 2001-9. PMID 25521358 DOI: 10.2217/Pgs.14.145 |
0.039 |
|
| 2010 |
Jones HE, Burns L, Gourarier L, Peles E, Springer-Kremser M, Fischer G. A multi-national pre-consensus survey: The principles of treatment of substance use disorders during pregnancy Journal of Global Drug Policy and Practice. 4. |
0.037 |
|
| 2023 |
Sadhu RK, Hernandez-Padilla C, Eisenbach YE, Penič S, Zhang L, Vishwasrao HD, Behkam B, Konstantopoulos K, Shroff H, Iglič A, Peles E, Nain AS, Gov NS. Author Correction: Experimental and theoretical model for the origin of coiling of cellular protrusions around fibers. Nature Communications. 14: 8518. PMID 38129398 DOI: 10.1038/s41467-023-44423-4 |
0.037 |
|
| 2009 |
Peles E, Schreiber S, Adelson M. Pathological gambling and obsessive compulsive disorder among methadone maintenance treatment patients Journal of Addictive Diseases. 28: 199-207. PMID 20155588 DOI: 10.1080/10550880903014106 |
0.037 |
|
| 2015 |
Levran O, Peles E, Randesi M, Correa da Rosa J, Ott J, Rotrosen J, Adelson M, Kreek MJ. Susceptibility loci for heroin and cocaine addiction in the serotonergic and adrenergic pathways in populations of different ancestry. Pharmacogenomics. 1-14. PMID 26227246 DOI: 10.2217/Pgs.15.86 |
0.033 |
|
| 1998 |
Modan M, Peles E, Halkin H, Nitzan H, Azaria M, Gitel S, Dolfin D, Modan B. Increased cardiovascular disease mortality rates in traumatic lower limb amputees American Journal of Cardiology. 82: 1242-1247. PMID 9832102 DOI: 10.1016/S0002-9149(98)00601-8 |
0.032 |
|
| 2013 |
Peles E, Schreiber S, Adelson M. Opiate-dependent patients on a waiting list for methadone maintenance treatment are at high risk for mortality until treatment entry. Journal of Addiction Medicine. 7: 177-82. PMID 23519049 DOI: 10.1097/ADM.0b013e318287cfc9 |
0.029 |
|
| 2014 |
Levy-Gigi E, Kéri S, Shapiro AR, Sason A, Adelson M, Peles E. Methadone maintenance patients show a selective deficit to reverse positive outcomes in drug-related conditions compared to medication free prolonged opiate abstinence. Drug and Alcohol Dependence. 144: 111-8. PMID 25220895 DOI: 10.1016/j.drugalcdep.2014.08.016 |
0.028 |
|
| 2011 |
Peles E, Schreiber S, Rados V, Adelson M. Low risk for hepatitis c seroconversion in methadone maintenance treatment Journal of Addiction Medicine. 5: 214-220. PMID 21844836 DOI: 10.1097/ADM.0b013e31820e13dd |
0.027 |
|
| 2016 |
Levran O, Peles E, Randesi M, Correa da Rosa J, Ott J, Rotrosen J, Adelson M, Kreek MJ. Glutamatergic and GABAergic susceptibility loci for heroin and cocaine addiction in subjects of African and European ancestry. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 64: 118-23. PMID 26277529 DOI: 10.1016/J.Pnpbp.2015.08.003 |
0.027 |
|
| 2006 |
Peles E, Schreiber S, Adelson M. Variables associated with perceived sleep disorders in methadone maintenance treatment (MMT) patients Drug and Alcohol Dependence. 82: 103-110. PMID 16154297 DOI: 10.1016/j.drugalcdep.2005.08.011 |
0.025 |
|
| 2010 |
Peles E, Schreiber S, Linzy S, Adelson M. Pathological gambling in methadone maintenance clinics where gambling is legal versus illegal American Journal of Orthopsychiatry. 80: 311-316. PMID 20636936 DOI: 10.1111/j.1939-0025.2010.01034.x |
0.024 |
|
| 2008 |
Schreiber S, Barkai G, Gur-Hartman T, Peles E, Tov N, Dolberg OT, Pick CG. Long-lasting sleep patterns of adult patients with minor traumatic brain injury (mTBI) and non-mTBI subjects Sleep Medicine. 9: 481-487. PMID 17638592 DOI: 10.1016/j.sleep.2007.04.014 |
0.024 |
|
| 2011 |
Potik D, Abramsohn Y, Peles E, Schreiber S, Adelson M. Working in the Conflict-Free Sphere: Adaptation Group in Methadone Maintenance Treatment Journal of Groups in Addiction and Recovery. 6: 285-306. DOI: 10.1080/1556035X.2011.614521 |
0.023 |
|
| 1995 |
Peles E, Akselrod S, Goldstein DS, Nitzan H, Azaria M, Almog S, Dolphin D, Halkin H, Modan M. Insulin resistance and autonomic function in traumatic lower limb amputees. Clinical Autonomic Research : Official Journal of the Clinical Autonomic Research Society. 5: 279-88. PMID 8563461 DOI: 10.1007/BF01818893 |
0.023 |
|
| 2007 |
Peles E, Rados V, Adelson M. Characterization of former heroin addict patients with hepatitis C virus antibodies in a methadone maintenance treatment (MMT) clinic in Israel Substance Use and Misuse. 42: 1477-1484. PMID 17886143 DOI: 10.1080/10826080701212550 |
0.021 |
|
| 2002 |
Cohen ZR, Ram Z, Knoller N, Peles E, Hadani M. Management and outcome of non-traumatic cerebellar haemorrhage Cerebrovascular Diseases. 14: 207-213. PMID 12403953 DOI: 10.1159/000065666 |
0.021 |
|
| 2013 |
Levran O, Peles E, Hamon S, Randesi M, Adelson M, Kreek MJ. CYP2B6 SNPs are associated with methadone dose required for effective treatment of opioid addiction. Addiction Biology. 18: 709-16. PMID 21790905 DOI: 10.1111/J.1369-1600.2011.00349.X |
0.02 |
|
| 2012 |
Peles E, Schreiber S, Sutzman A, Adelson M. Attention deficit hyperactivity disorder and obsessive-compulsive disorder among former heroin addicts currently in methadone maintenance treatment. Psychopathology. 45: 327-33. PMID 22796643 DOI: 10.1159/000336219 |
0.02 |
|
| 2013 |
Ben Bassat OK, Peles E, Schreiber S, Adelson M, Zeltser D, Viskin S, Adler A. Response of QT interval in methadone maintenance treated patients to the rapid changes in heart rate provoked by brisk standing: comparison to healthy controls and patients with long QT syndrome. Journal of Electrocardiology. 46: 519-23. PMID 24035102 DOI: 10.1016/j.jelectrocard.2013.08.011 |
0.02 |
|
| 2005 |
Peles E, Bodner G, Adelson M. Correlation between high methadone dose and methadone blood level in methadone maintenance treatment patients Heroin Addiction and Related Clinical Problems. 7: 27-32. |
0.02 |
|
| 2010 |
Peles E, Schreiber S, Adelson M. 15-Year survival and retention of patients in a general hospital-affiliated methadone maintenance treatment (MMT) center in Israel Drug and Alcohol Dependence. 107: 141-148. PMID 19914783 DOI: 10.1016/j.drugalcdep.2009.09.013 |
0.02 |
|
| 1995 |
Peles E, Goldstein DS, Akselrod S, Nitzan H, Azaria M, Almog S, Dolphin D, Halkin H, Modan M. Interrelationships among measures of autonomic activity and cardiovascular risk factors during orthostasis and the oral glucose tolerance test. Clinical Autonomic Research : Official Journal of the Clinical Autonomic Research Society. 5: 271-8. PMID 8563460 DOI: 10.1007/BF01818892 |
0.02 |
|
| 2009 |
Peles E, Adelson M, Schreiber S. Association of OCD with a history of traumatic events among patients in methadone maintenance treatment Cns Spectrums. 14: 547-554. PMID 20095367 |
0.019 |
|
| 2014 |
Adelson M, Schreiber S, Sason A, Peles E. Are 2 weeks of "take-home" privileges beneficial for patients' long-term outcome in a methadone maintenance treatment program? Journal of Addiction Medicine. 8: 170-5. PMID 24440893 DOI: 10.1097/ADM.0000000000000011 |
0.019 |
|
| 2013 |
Peles E, Linzy S, Kreek MJ, Adelson M. Prospective study of QTc changes among former opiate addicts since admission to methadone maintenance treatment: benzodiazepine risk. Journal of Addiction Medicine. 7: 428-34. PMID 24145160 DOI: 10.1097/Adm.0B013E3182A8A4F2 |
0.019 |
|
| 2014 |
Peles E, Schreiber S, Adelson M. Trends in substance abuse and infectious disease over 20 years in a large methadone maintenance treatment (MMT) clinic in Israel. Substance Abuse. 35: 226-9. PMID 24701983 DOI: 10.1080/08897077.2014.899944 |
0.018 |
|
| 2014 |
Peles E, Weinstein A, Sason A, Adelson M, Schreiber S. Stroop task among patients with obsessive-compulsive disorder (OCD) and pathological gambling (PG) in methadone maintenance treatment (MMT). Cns Spectrums. 19: 509-18. PMID 24360394 DOI: 10.1017/S1092852913000862 |
0.018 |
|
| 2015 |
Peles E, Linzy S, Sason A, Tene O, Adelson M. Is Internet Addiction Prevalent Among Methadone Maintenance Treatment Patients? Data from Las Vegas and Tel Aviv. Journal of Addictive Diseases. 34: 296-302. PMID 26284288 DOI: 10.1080/10550887.2015.1074503 |
0.018 |
|
| 2008 |
Schreiber S, Peles E, Adelson M. Association between improvement in depression, reduced benzodiazepine (BDZ) abuse, and increased psychotropic medication use in methadone maintenance treatment (MMT) patients Drug and Alcohol Dependence. 92: 79-85. PMID 17706374 DOI: 10.1016/j.drugalcdep.2007.06.016 |
0.018 |
|
| 2007 |
Peles E, Hetzroni T, Bar-Hamburger R, Adelson M, Schreiber S. Melatonin for perceived sleep disturbances associated with benzodiazepine withdrawal among patients in methadone maintenance treatment: A double-blind randomized clinical trial Addiction. 102: 1947-1953. PMID 17916225 DOI: 10.1111/j.1360-0443.2007.02007.x |
0.017 |
|
| 2011 |
Peles E, Schreibe S, Sason A, Adelson M. Earning "Take-Home" privileges and long-term outcome in a methadone maintenance treatment program Journal of Addiction Medicine. 5: 92-98. PMID 21769054 DOI: 10.1097/ADM.0b013e3181e6ad48 |
0.016 |
|
| 2012 |
Peles E, Schreiber S, Bloch M, Dollberg S, Adelson M. Duration of methadone maintenance treatment during pregnancy and pregnancy outcome parameters in women with opiate addiction Journal of Addiction Medicine. 6: 18-23. PMID 21817914 DOI: 10.1097/ADM.0b013e318229bb25 |
0.016 |
|
| 2014 |
Peles E, Schreiber S, Domany Y, Sason A, Tene O, Adelson M. Achievement of take-home dose privileges is associated with better-perceived sleep and with cognitive status among methadone maintenance treatment patients. The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry. 15: 620-8. PMID 24666249 DOI: 10.3109/15622975.2014.897003 |
0.016 |
|
| 2012 |
Peles E, Schreiber S, Sason A, Adelson M. Long waiting period to enter methadone maintenance treatment: Relation to patient characteristics and outcome European Addiction Research. 18: 149-152. PMID 22398696 DOI: 10.1159/000336313 |
0.016 |
|
| 2014 |
Peles E, Adelson M, Seligman Z, Bloch M, Potik D, Schreiber S. Psychiatric comorbidity differences between women with history of childhood sexual abuse who are methadone-maintained former opiate addicts and non-addicts. Psychiatry Research. 219: 191-7. PMID 24908543 DOI: 10.1016/j.psychres.2014.05.003 |
0.016 |
|
| 2008 |
Peles E, Schreiber S, Adelson M. Tricyclic antidepressants abuse, with or without benzodiazepines abuse, in former heroin addicts currently in methadone maintenance treatment (MMT) European Neuropsychopharmacology. 18: 188-193. PMID 17997285 DOI: 10.1016/j.euroneuro.2007.10.001 |
0.016 |
|
| 2007 |
Peles E, Schreiber S, Naumovsky Y, Adelson M. Depression in methadone maintenance treatment patients: Rate and risk factors Journal of Affective Disorders. 99: 213-220. PMID 17055063 DOI: 10.1016/j.jad.2006.09.017 |
0.016 |
|
| 2006 |
Peles E, Schreiber S, Adelson M. Factors predicting retention in treatment: 10-year experience of a methadone maintenance treatment (MMT) clinic in Israel Drug and Alcohol Dependence. 82: 211-217. PMID 16219428 DOI: 10.1016/j.drugalcdep.2005.09.004 |
0.015 |
|
| 2007 |
Peles E, Bodner G, Kreek MJ, Rados V, Adelson M. Corrected-QT intervals as related to methadone dose and serum level in methadone maintenance treatment (MMT) patients: a cross-sectional study. Addiction (Abingdon, England). 102: 289-300. PMID 17222284 DOI: 10.1111/j.1360-0443.2006.01668.x |
0.015 |
|
| 2013 |
Adelson M, Wilson HW, Celeste VY, Linzy S, Kreek MJ, Peles E. Methadone maintenance treatment experience in Macao--prospective follow-up for initial 4.5 years. Journal of Psychoactive Drugs. 45: 313-21. PMID 24377170 DOI: 10.1080/02791072.2013.825032 |
0.014 |
|
| 2014 |
Peles E, Adelson M, Schreiber S. Benzodiazepine usage during 19.5 years in methadone maintenance treatment patients and its relation to long-term outcome. The Israel Journal of Psychiatry and Related Sciences. 51: 285-8. PMID 25841226 |
0.014 |
|
| 2007 |
Adelson M, Peles E, Bodner G, Kreek MJ. Correlation between high methadone doses and methadone serum levels in methadone maintenance treatment (MMT) patients. Journal of Addictive Diseases. 26: 15-26. PMID 17439864 DOI: 10.1300/J069v26n01_03 |
0.014 |
|
| 2011 |
Peles E, Schreiber S, Bar Hamburger R, Adelson M. No Change of Sleep after 6 and 12 months of methadone maintenance treatment Journal of Addiction Medicine. 5: 141-147. PMID 21769060 DOI: 10.1097/ADM.0b013e3181e8b6c4 |
0.014 |
|
| 2005 |
Peles E, Schreiber S, Gordon J, Adelson M. Significantly higher methadone dose for methadone maintenance treatment (MMT) patients with chronic pain Pain. 113: 340-346. PMID 15661442 DOI: 10.1016/j.pain.2004.11.011 |
0.014 |
|
| 2014 |
Peles E, Schreiber S, Adelson M. Deleterious effects of benzodiazepine abuse among methadone maintenance treatment patients Heroin Addiction and Related Clinical Problems. 16: 63-70. |
0.013 |
|
| 2001 |
Peles E, Barell V, Boyko V, Ziv A, Kaplan G. Traumatic brain injury--the National Trauma Registry Harefuah. 140: 381-385, 455. PMID 11419056 |
0.013 |
|
| 2014 |
Peles E, Schreiber S, Adelson M. Treatment outcome unaffected by initiation of full weekend closure of methadone maintenance treatment clinic. Journal of Addictive Diseases. 33: 77-82. PMID 24717114 DOI: 10.1080/10550887.2014.909699 |
0.013 |
|
| 2014 |
Potik D, Peles E, Abramsohn Y, Adelson M, Schreiber S. The relationship between vulnerable attachment style, psychopathology, drug abuse, and retention in treatment among methadone maintenance treatment patients. Journal of Psychoactive Drugs. 46: 325-33. PMID 25188703 DOI: 10.1080/02791072.2014.944290 |
0.013 |
|
| 2015 |
Peles E, Sason A, Tene O, Domany Y, Schreiber S, Adelson M. Ten years of abstinence in former opiate addicts: medication-free non-patients compared to methadone maintenance patients. Journal of Addictive Diseases. 0. PMID 26284418 DOI: 10.1080/10550887.2015.1074502 |
0.013 |
|
| 2009 |
Abramsohn Y, Peles E, Potik D, Schreiber S, Adelson M. Sense of coherence as a stable predictor for methadone maintenance treatment (MMT) outcome Journal of Psychoactive Drugs. 41: 249-253. PMID 19999678 |
0.012 |
|
| 2014 |
Peles E, Schreiber S, Domany Y, Adelson M. Impact of lifetime psychiatric diagnosis on long-term retention and survival of former opiate addicts in methadone maintenance treatment. The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry. 15: 629-35. PMID 25140586 DOI: 10.3109/15622975.2014.942359 |
0.012 |
|
| 2009 |
Peles E, Schreiber S, Adelson M. Documented poor sleep among methadone-maintained patients is associated with chronic pain and benzodiazepine abuse, but not with methadone dose European Neuropsychopharmacology. 19: 581-588. PMID 19411166 DOI: 10.1016/j.euroneuro.2009.04.001 |
0.011 |
|
| 2015 |
Peles E, Schreiber S, Linzy S, Domani Y, Adelson M. Differences in methylphenidate abuse rates among methadone maintenance treatment patients in two clinics. Journal of Substance Abuse Treatment. 54: 44-9. PMID 25605438 DOI: 10.1016/j.jsat.2014.12.010 |
0.01 |
|
| 2014 |
Peles E, Sason A, Bloch M, Maslovitz S, Dollberg S, Many A, J Kuperminc M, Adelson M. The Prevalence of Alcohol, Substance and Cigarettes Exposure among Pregnant Women within a General Hospital and the Compliance to Brief Intervention for Exposure Reduction. The Israel Journal of Psychiatry and Related Sciences. 51: 248-56. PMID 25841220 |
0.01 |
|
| 2012 |
Peles E, Potik D, Schreiber S, Bloch M, Adelson M. Psychiatric comorbidity of patients on methadone maintenance treatment with a history of sexual abuse. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 22: 883-91. PMID 22564825 DOI: 10.1016/j.euroneuro.2012.04.002 |
0.01 |
|
| 2011 |
Peles E, Schreiber S, Hetzroni T, Adelson M, Defrin R. The differential effect of methadone dose and of chronic pain on pain perception of former heroin addicts receiving methadone maintenance treatment Journal of Pain. 12: 41-50. PMID 20561825 DOI: 10.1016/j.jpain.2010.04.009 |
0.01 |
|
| 2008 |
Peles E, Linzy S, Kreek MJ, Adelson M. One-year and cumulative retention as predictors of success in methadone maintenance treatment: A comparison of two clinics in the United States and Israel Journal of Addictive Diseases. 27: 11-25. PMID 19042587 DOI: 10.1080/10550880802324382 |
0.01 |
|
| 2007 |
Schreiber S, Dolberg OT, Barkai G, Peles E, Leor A, Rapoport E, Heinik J, Bloch M. Primary intervention for memory structuring and meaning acquisition (PIMSMA): study of a mental health first-aid intervention in the ED with injured survivors of suicide bombing attacks American Journal of Disaster Medicine. 2: 307-320. PMID 18297951 |
0.01 |
|
| 2006 |
Peles E, Adelson M. Gender differences and pregnant women in a Methadone Maintenance Treatment (MMT) clinic Journal of Addictive Diseases. 25: 39-45. PMID 16785218 DOI: 10.1300/J069v25n02_06 |
0.01 |
|
| 2006 |
Peles E, Kreek MJ, Kellogg S, Adelson M. High methadone dose significantly reduces cocaine use in methadone maintenance treatment (MMT) patients. Journal of Addictive Diseases. 25: 43-50. PMID 16597572 DOI: 10.1300/J069V25N01_07 |
0.01 |
|
| Hide low-probability matches. |